Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mead

Showing results (371-380 of 435) with videos related to

Pageof 44
Sort By:
Blood|August 5, 2011
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationShabnam Kharazi, Adam J Mead, Anna Mansour, et al.
Blood|March 29, 2013
Impact of isolated germline JAK2V617I mutation on human hematopoiesisAdam J Mead, Onima Chowdhury, Christian Pecquet, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Therapeutic Advances in Hematology|April 4, 2022
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK studyAdam J Mead, Nauman M Butt, Waseem Nagi, et al.
Cell Reports|June 4, 2013
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitorsAdam J Mead, Shabnam Kharazi, Deborah Atkinson, et al.
Frontiers in Aging Neuroscience|May 30, 2023
A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterationsScott P Allen, Afnan Al Sultan, Elaine Kabucho Kibirige, et al.
Brain Pathology (Zurich, Switzerland)|July 24, 2022
Atypical TDP-43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBPJohnathan Cooper-Knock, Thomas H Julian, Emily Feneberg, et al.
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
The Journal of Experimental Medicine|November 6, 2020
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell functionChristopher Mapperley, Louie N van de Lagemaat, Hannah Lawson, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Pageof 44

Showing results (371-380 of 435) with videos related to

Sort By:
Pageof 44
Blood|August 5, 2011
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationShabnam Kharazi, Adam J Mead, Anna Mansour, et al.
Blood|March 29, 2013
Impact of isolated germline JAK2V617I mutation on human hematopoiesisAdam J Mead, Onima Chowdhury, Christian Pecquet, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Therapeutic Advances in Hematology|April 4, 2022
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK studyAdam J Mead, Nauman M Butt, Waseem Nagi, et al.
Cell Reports|June 4, 2013
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitorsAdam J Mead, Shabnam Kharazi, Deborah Atkinson, et al.
Frontiers in Aging Neuroscience|May 30, 2023
A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterationsScott P Allen, Afnan Al Sultan, Elaine Kabucho Kibirige, et al.
Brain Pathology (Zurich, Switzerland)|July 24, 2022
Atypical TDP-43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBPJohnathan Cooper-Knock, Thomas H Julian, Emily Feneberg, et al.
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
The Journal of Experimental Medicine|November 6, 2020
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell functionChristopher Mapperley, Louie N van de Lagemaat, Hannah Lawson, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Pageof 44